Back to User profile » Dr Shinji Matsunaga
Papers published by Dr Shinji Matsunaga:
Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging: a case report
Kitaguchi N, Kato T, Matsunaga S, Hirano K, Iwata K, Kawaguchi K, Fujita K, Takechi H, Hasegawa M, Yuzawa Y, Ito K
Neuropsychiatric Disease and Treatment 2018, 14:2931-2937
Published Date: 1 November 2018
Memantine treatment for Japanese patients with moderate to severe Alzheimer’s disease: a meta-analysis of double-blind, randomized, placebo-controlled trials
Kishi T, Matsunaga S, Iwata N
Neuropsychiatric Disease and Treatment 2018, 14:2915-2922
Published Date: 30 October 2018
The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis
Kishi T, Matsunaga S, Iwata N
Neuropsychiatric Disease and Treatment 2017, 13:1909-1928
Published Date: 20 July 2017
Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population
Kishi T, Ikuta T, Matsunaga S, Matsuda Y, Oya K, Iwata N
Neuropsychiatric Disease and Treatment 2017, 13:1281-1302
Published Date: 11 May 2017
Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
Kishi T, Matsuda Y, Matsunaga S, Moriwaki M, Otake Y, Akamatsu K, Okochi T, Hirano S, Funahashi T, Okuda M, Tabuse H, Fujita K, Iwata N
Neuropsychiatric Disease and Treatment 2017, 13:117-125
Published Date: 6 January 2017
Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
Okuyama Y, Oya K, Matsunaga S, Kishi T, Iwata N
Neuropsychiatric Disease and Treatment 2016, 12:3221-3236
Published Date: 15 December 2016
A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders
Kishi T, Matsuda Y, Matsunaga S, Mukai T, Moriwaki M, Tabuse H, Fujita K, Iwata N
Neuropsychiatric Disease and Treatment 2016, 12:3041-3049
Published Date: 28 November 2016
Memantine for the treatment of frontotemporal dementia: a meta-analysis
Kishi T, Matsunaga S, Iwata N
Neuropsychiatric Disease and Treatment 2015, 11:2883-2885
Published Date: 12 November 2015
Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials
Kishi T, Matsuda Y, Matsunaga S, Iwata N
Neuropsychiatric Disease and Treatment 2015, 11:419-434
Published Date: 20 February 2015
Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine
Kishi T, Matsunaga S, Matsuda Y, Iwata N
Neuropsychiatric Disease and Treatment 2014, 10:2339-2351
Published Date: 10 December 2014